Prehospital treatment of patients with acute myocardial infarction with bivalirudin

American Journal of Emergency Medicine

Volumn 30, Issue 1, 2012, Pages 12-17

  Hirschl, Michael M ^a   Mayr, Harald ^a   Erhart, Friedrich ^b   Brunner, Walter ^b   Steger, Friedrich ^b   Gattermeier, Martin ^b   Pfeffel, Franz ^b  

^a Karl Landsteiner Institute for Implementation of Innovative Techniques in Cardiac Surgery   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; HEPARIN; HIRULOG;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; EMERGENCY CARE; EMERGENCY WARD; FATALITY; FEMALE; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; ANTITHROMBINS; DRUG THERAPY, COMBINATION; EMERGENCY MEDICAL SERVICES; FEMALE; HEART CATHETERIZATION; HEMORRHAGE; HEPARIN; HIRUDINS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; TIME FACTORS; TREATMENT OUTCOME;

EID: 81755171901     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2010.09.010     Document Type: Article

References (18)

1. Antman E.M., Hand M., Armstrong P.W., and Bates E.R. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee Circulation 117 2008 296 329
2. Van de Werf F., Bax J., and Betriu A. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
3. Andersen H.R., Nielsen T.T., and Rasmussen K. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 2003 733 742
4. Hassan A.K., Liem S.S., and van der Kley F. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program Catheter Cardiovasc Interv 74 2009 335 343
5. Van't Hof A.W., Ten Berg J., and Heestermans T. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial Lancet 372 2008 537 546
6. Ellis S.G., Tendera M., and de Belder M.A. Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 2008 2205 2217
7. Rajagopal V., Lincoff A.M., and Cohen D.J. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial Am Heart J 152 2006 149 154
8. White H.D., Ohman E.M., and Lincoff A.M. Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial J Am Coll Cardiol 52 2008 807 814
9. Stone G.W., Witzenbichler B., and Guagliumi G. Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
10. Sejersten M., Nielsen S.L., and Engström T. Feasibility and safety of prehospital administration of bivalirudin in patients with ST-elevation myocardial infarction Am J Cardiol 103 2009 1635 1640
11. Nikolsky E., Mehran R., and Sadeghi H.M. Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial JACC Cardiovasc Interv 2 2009 624 632
12. Cohen M. Predictors of bleeding risk and long-term mortality in patients with acute coronary syndromes Curr Med Res Opin 21 2005 439 445
13. Kinnaird T.D., Stabile E., and Mintz G.S. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions Am J Cardiol 92 2003 930 935
14. Huikuri H.V., Castellanos A., and Myerburg R.J. Sudden death due to cardiac arrhythmias N Engl J Med 345 2001 1473 1482
15. Thiele H., Kappl M.J., and Linke A. Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging Eur Heart J 28 2007 1433 1439
16. Hassan A.K., Jukema J.W., and van der Laarse A. Incidence, patient characteristics and predictors of aborted myocardial infarction in patients undergoing primary PCI: prospective study comparing pre- and in-hospital abciximab pretreatment EuroIntervention 4 2009 662 668
17. Kalla K., Christ G., and Karnik R. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry) Circulation 113 2006 2398 2405
18. Reed M.D., and Bell D. Clinical pharmacology of bivalirudin Pharmacotherapy 22 2002 105S 111S